Chemical modification of class II G protein-coupled receptor ligands: frontiers in the development of peptide analogs as neuroendocrine pharmacological therapies

Chemical modification of class II G protein-coupled receptor ligands: frontiers in the development of peptide analogs as neuroendocrine pharmacological therapies

Item
http://www.wikidata.org/entity/Q33624771
Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disordersSystems-Level G Protein-Coupled Receptor Therapy Across a Neurodegenerative Continuum by the GLP-1 Receptor SystemIdentification of residue-to-residue contact between a peptide ligand and its G protein-coupled receptor using periodate-mediated dihydroxyphenylalanine cross-linking and mass spectrometryMetabolic and hormonal signatures in pre-manifest and manifest Huntington's disease patients.Transferrin fusion technology: a novel approach to prolonging biological half-life of insulinotropic peptidesTherapeutic potential of vasoactive intestinal peptide and its receptors in neurological disorders.Central role of the EGF receptor in neurometabolic aging.Neuropeptides: keeping the balance between pathogen immunity and immune toleranceCerebellum Transcriptome of Mice Bred for High Voluntary Activity Offers Insights into Locomotor Control and Reward-Dependent Behaviors.PACAP Inhibits β-cell Mass Expansion in a Mouse Model of Type II Diabetes: Persistent Suppressive Effects on Islet DensityMass spectrometry based tools to investigate protein-ligand interactions for drug discovery.Stabilized helical peptides: overview of the technologies and therapeutic promises.Structural aspects of gut peptides with therapeutic potential for type 2 diabetes.Mechanistic Contributions of Biological Cofactors in Islet Amyloid Polypeptide Amyloidogenesis.Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions.The Protective Role of PAC1-Receptor Agonist Maxadilan in BCCAO-Induced Retinal Degeneration.
P2860

Chemical modification of class II G protein-coupled receptor ligands: frontiers in the development of peptide analogs as neuroendocrine pharmacological therapies

Item
http://www.wikidata.org/entity/Q33624771
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Chemical modification of class ...... rine pharmacological therapies
@ast
Chemical modification of class ...... rine pharmacological therapies
@en
type
label
Chemical modification of class ...... rine pharmacological therapies
@ast
Chemical modification of class ...... rine pharmacological therapies
@en
prefLabel
Chemical modification of class ...... rine pharmacological therapies
@ast
Chemical modification of class ...... rine pharmacological therapies
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Chemical modification of class ...... rine pharmacological therapies
@en
P2093
P2860
P304
P31
P356
10.1016/J.PHARMTHERA.2009.07.006
P433
P478
P577
P5875
P698
P921
P932